Abstract
Vascular properties of the retina are not only indicative of ocular but also systemic cardio– and cerebrovascular health. Yet, the extent to which retinal vascular morphology reflects that in other organs is not well understood. We used morphological vascular phenotypes derived from the brain, the carotid artery, the aorta, and the retina from the UK Biobank, with sample sizes between 33,000 and 68,000 subjects per phenotype. We examined the cross-organ phenotypic and genetic correlations, as well as common associated genes and pathways. White matter hyperintensities positively correlated with carotid intima-media thickness and aortic cross-sectional areas but negatively correlated with aortic distensibility. Retinal vascular density showed negative correlations with white matter hyperintensities, intima-media thickness, and aortic areas, while positively correlating with aortic distensibility. Significant correlations were also observed between other retinal phenotypes and white matter hyperintensities, as well as with aortic phenotypes. Correcting for hypertension reduced the magnitude of these correlations, but the overall correlation structure largely persisted. Genetic correlations and gene enrichment analyses identified potential regulators of these phenotypes, with some shared genetic influence between retinal and non-retinal phenotypes. Our study sheds light on the complex interplay between vascular morphology across different organs, revealing both shared and distinct genetic underpinnings. This highlights the potential of retinal imaging as a non-invasive prognostic tool for systemic vascular health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: Supported by the Swiss National Science Foundation grant no. CRSII5 209510 for the VascX Sinergia project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We received the approval from the UK Biobank data when submitting the project proposal
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* E-mails: sofia.ortinvela{at}unil.ch, and sven.bergmann{at}unil.ch
Data Availability
All data produced in the present work are contained in the manuscript or available upon reasonable request to the authors
Nonstandard Abbreviations and Acronyms
- ASEG
- Automatic subcortical segmentation
- ASL
- Arterial spin labeling
- ATT
- Arterial transit time
- CBF
- Cerebral blood flow
- CFIs
- Color fundus images
- DBP
- Diastolic blood pressure
- FLAIR
- Fluid-attenuated inversion recovery
- IDP
- Image-derived phenotype
- IMT
- Intima-media thickness
- LDSR
- Linkage disequilibrium score regression
- MRA
- Magnetic resonance angiography
- MRI
- Magnetic resonance imaging
- PC
- Principal component
- SBP
- Systolic blood pressure
- UKBB
- UK Biobank
- WMH
- White matter hyperintensities